Eli Lilly and Company's top products based on revenue 2022-2023

In 2023, Trulicity was Eli Lilly's biggest revenue generator with about 7.1 billion U.S. dollars. The next highest revenue generating drug was Mounjaro with about 5.1 billion U.S. dollars. Eli Lilly is a multi-national pharmaceutical company that is headquartered in Indianapolis, Indiana.

Eli Lilly Company

Eli Lilly was founded in 1876 in the United States. As of today, the company has around 39 thousand employees globally. The company specializes in global health initiatives, diabetes care and a multitude of other products concerning human health. Eli Lilly currently markets products in over 120 countries globally. As of 2022, the company was among the top pharmaceutical companies based on both prescription sales and research and development spending.

Diabetes products by Eli Lilly

Eli Lilly is the manufacturer of several of the global top diabetic pharmaceutical products and treatments. As of 2023, Eli Lilly was the second ranked diabetes-focused pharmaceutical company based on revenue. Globally, Trulicity, one of Eli Lilly’s top drugs used in the treatment of type II diabetes, is projected to stay one of the top anti-diabetics in the near future.